ivosidenib tablets
for oral use Initial U.S. Approval: 2018

Tibosovo (ivosidenib) is a prescription medicine used to treat adults with an IDH1 mutation who have: Acute myeloid leukemia (AML) that is either newly-diagnosed or relapsed/refractory, or Locally advanced or metastatic bile duct cancer (cholangiocarcinoma).

Facts about ivosidenib tablets

Disease Indications-Leukemia, Bile Duct Cancer
Manufacturer-Agios Pharmaceuticals, Inc.
Usage-Oral
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ivosidenib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.